Related Experiment Video

Updated: Jun 4, 2026

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
11:34

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Published on: December 5, 2017

[Standardization of quantitative detection of human epidermal growth factor receptor 2 in invasive breast cancer:

Ting Li

    Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]
    |July 15, 2009
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
    11:12

    Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

    Published on: August 1, 2018

    Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells
    08:28

    Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells

    Published on: May 9, 2025

    Related Experiment Videos

    Last Updated: Jun 4, 2026

    Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
    11:34

    Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

    Published on: December 5, 2017

    Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
    11:12

    Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

    Published on: August 1, 2018

    Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells
    08:28

    Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells

    Published on: May 9, 2025

    Related Concept Videos

    Mitogens and the Cell Cycle02:38

    Mitogens and the Cell Cycle

    Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...

    Articles linked to this work by shared authors, journal, and citation graph.

    Anatomic distribution of nerves and microvascular density in the human anterior vaginal wall: prospective study.

    PloS one·2014

    CSBF/C10orf99, a novel potential cytokine, inhibits colon cancer cell growth through inducing G1 arrest.

    Scientific reports·2014

    V‑set and transmembrane domain‑containing 1 is silenced in human hematopoietic malignancy cell lines with promoter methylation and has inhibitory effects on cell growth.

    Molecular medicine reports·2014

    [Evaluation and indication of human epithelial growth factor receptor 2 status in breast carcinoma with amplified chromosome].

    Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences·2014

    [Role of magnetic resonance imaging for response evaluation and predictive value of tumor biomarkers in the neoadjuvant chemotherapy for breast cancer:a multi-center prospective study].

    Zhonghua yi xue za zhi·2014

    Glucocorticoid-induced S-adenosylmethionine enhances the interferon signaling pathway by restoring STAT1 protein methylation in hepatitis B virus-infected cells.

    The Journal of biological chemistry·2014

    [Research progress on cerebral hypoperfusion following revascularization for carotid artery stenotic disease].

    Zhonghua wai ke za zhi [Chinese journal of surgery]·2026

    [Preoperative levator ani complex volume predicts severe low anterior resection syndrome after intersphincteric resection: development and validation of a nomogram model].

    Zhonghua wai ke za zhi [Chinese journal of surgery]·2026

    [Acute pancreatitis in pancreatic cancer: impact on prognosis:a retrospective single-center cohort study].

    Zhonghua wai ke za zhi [Chinese journal of surgery]·2026

    [Efficacy of percutaneous mechanical thrombectomy combined with transjugular intrahepatic portosystemic shunt for acute non-cirrhotic portal vein thrombosis].

    Zhonghua wai ke za zhi [Chinese journal of surgery]·2026

    [Dominant false lumen flow and abnormally high shear stress: a hemodynamic analysis of multichanneled aortic dissection].

    Zhonghua wai ke za zhi [Chinese journal of surgery]·2026

    [Value of a CT angiography-based deep learning model for differentiating SVS grade Ⅱ and grade Ⅲ blunt thoracic aortic injury: a retrospective multicenter staged study].

    Zhonghua wai ke za zhi [Chinese journal of surgery]·2026

    Effect of Screening with Multicancer Early-Detection Test on Late-Stage Cancer Diagnosis.

    The New England journal of medicine·2026

    Rethinking Preoperative MRI in Early Breast Cancer: Who Truly Benefits?

    European journal of breast health·2026

    18F-CETO in Adrenocortical Carcinoma: First Clinical-Translational Study of An Adrenocortical-targeting PET Tracer.

    Endocrine-related cancer·2026

    Improving the Early Detection of Hepatocellular Carcinoma in Patients with Chronic Liver Disease: An Integrated C-GALAD Model and Cell-Free DNA Approach.

    The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology·2026

    Photodynamic Diagnosis of Actinic Keratosis: A Systematic Review.

    Acta dermato-venereologica·2026

    Recommendations of the American Cancer Society workshop on design, conduct, analysis, and reporting of multicancer early detection trials with late-stage incidence end points and post-trial ongoing evaluation-The Peachtree Consensus.

    Cancer·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us